| June 23, 2021 |
Letter to EPA on the development and submission of analytical methods under TSCA Sections 4 and 8 |
| May 17, 2021 |
Comments to EPA on the final rules for five persistent, bioaccumulative and toxic (PBT) chemicals |
| April 7, 2021 |
Letter to EPA on a new direction for the TSCA PMN Program |
| March 26, 2021 |
Comments to EPA on proposed fees for the administration of the amended TSCA |
| March 23, 2021 |
Letter to EPA on the need for the agency to put public health, science and equity at the center of its mission |
| February 26, 2021 |
Letter to EPA on political interference in the TSCA TCE risk evaluation by the prior administration |
| February 5, 2021 |
Letter to EPA calling for immediate action on methylene chloride under TSCA |
| January 22, 2021 |
Letter to EPA stating request to rescind January 19 Compliance Guide for PFAS SNUR under TSCA |
| January 15, 2021 |
Comments to EPA on Draft Compliance Guide for Imported Articles Containing Surface Coatings Subject to the Long-Chain Perfluoroalkyl Carboxylate and Perfluoroalkyl Sulfonate Chemical Substances Significant New Use Rule (SNUR) |
| December 19, 2020 |
Comments to EPA on Revised Draft Risk Evaluation for C.I. Pigment Violet 29 |
| December 2020 |
Principles of Risk Management under TSCA Section 6 |
| November 23, 2020 |
Letter to EPA requesting an extension of the comment period for the 1,4-dioxane supplemental risk evaluation |
| August 27, 2020 |
Letter to EPA expressing concern on the lack of opportunity to comment on two recent requests for critical use exemptions from EPA’s PBT rule |
| July 6, 2020 |
Comments on EPA’s Draft Risk Evaluation for Perchloroethylene |
| June 19, 2020 |
Letter to EPA on unannounced changes in EPA model consent order under Section 5(e) of TSCA |
| June 10, 2020 |
Comments on EPA’s Regulatory Determination on PFOA and PFOS under the Safe Drinking Water Act |
| June 8, 2020 |
Comments on EPA’s draft scoping documents for seven high-priority substances |
| June 2, 2020 |
Comments on EPA’s Draft Risk Evaluation for Asbestos |
| April 27, 2020 |
Comments on EPA’s Draft Risk Evaluation for Trichloroethylene |
| April 17, 2020 |
Comments on EPA’s Supplemental Significant New Use Proposal for Long-Chain Perfluoroalkyl Carboxylate and Perfluoroalkyl Sulfonate Chemical Substances |
| March 18, 2020 |
Comments to Science Advisory Committee on Chemicals (SACC) on EPA’s Draft Risk Evaluation for Trichloroethylene |
| March 6, 2020 |
Letter to EPA on imminent and serious health risks from acute consumer and worker exposure to trichloroethylene (TCE) |
| February 19, 2020 |
Comments to Science Advisory Committee on Chemicals (SACC) on EPA’s Draft Risk Evaluation for Carbon Tetrachloride |
| February 18, 2020 |
Comments to EPA on the agency’s working approach for making new chemical determinations under TSCA Section 5 |
| January 21, 2020 |
Comments on EPA’s Draft Risk Evaluation for N-Methylpyrrolidone (NMP) |
| December 30, 2019 |
Comments on EPA’s Draft Risk Evaluation for Methylene Chloride |
| November 26, 2019 |
Comments to Science Advisory Committee on Chemicals (SACC) on EPA’s Draft Risk Evaluation for Methylene Chloride |
| November 21, 2019 |
Comments on proposed high-priority substance designation |
| November 13, 2019 |
Comments on proposed low-priority substance designation |
| November 8, 2019 |
Letter to EPA on imminent and serious health risks from acute consumer and worker exposure to methylene chloride |
| October 28, 2019 |
Comments on EPA’s proposed rule regulating persistent, bioaccumulative and toxic chemicals under TSCA |
| October 11, 2019 |
Comments on EPA’s Draft Risk Evaluation for 1-Bromopropane |
| October 9, 2019 |
Letter to EPA on imminent and serious health risks from acute consumer and worker exposure to 1-bromopropane; A background paper on the risks was also sent to EPA. |
| October 7, 2019 |
Comments on new chemical submissions for four PFAS chemicals |
| August 30, 2019 |
Comments on EPA’s Draft Risk Evaluation for Cyclic Aliphatic Bromide Cluster (HBCD) |
| August 30, 2019 |
Comments on EPA’s Draft Risk Evaluation for 1,4-Dioxane |
| June 24, 2019 |
Comments on EPA’s Proposed Revisions and Small Manufacturer Definition Update for Chemical Data Reporting Under TSCA Section 8(a) |
| June 19, 2019 |
Comments on EPA’s Initiation of Prioritization for 20 High-Priority and 20 Low-Priority Candidates under Section 6(b)(1) of TSCA |
| May 28, 2019 |
Comments on EPA’s Advance Notice of Proposed Rulemaking for Methylene Chloride Commercial Paint and Coating Removal Training, Certification and Limited Access Program |
| May 17, 2019 |
Supplemental comments on EPA’s Draft Risk Evaluation for C.I. Pigment Violet 29 |
| January 14, 2019 |
Comments on EPA’s Draft Risk Evaluation for C.I. Pigment Violet 29 and Supplemental Information to Comments |
| November 15, 2018 |
Comments on EPA’s Working Approach for identifying potential candidate chemicals for prioritization |
| November 15, 2018 |
Comments on proposed SNURs on certain chemical substances under Section 5 of TSCA |
| October 30, 2018 |
Letter to EPA on public comment and peer review process for the initial 10 risk evaluations under TSCA |
| August 17, 2018 |
Comments on EPA Exposure and Use Assessment and Environmental and Human Health Hazards of 5 PBTs |
| August 16, 2018 |
Comments on problem formulations for the risk evaluations of 10 chemical substances under TSCA; appendices focusing on individual chemicals were also submitted for 1-BP, asbestos, carbon tetrachloride, HBCD, and NMP; The Healthy Building Network’s report on Chlorine and Building Materials was also submitted as an attachment in the asbestos and carbon tetrachloride dockets |
| August 16, 2018 |
Comments on proposed rule strengthening “transparency” in regulatory science |
| August 16, 2018 |
Comments on application of systematic review in risk evaluations under TSCA Section 6 |
| August 10, 2018 |
Comments on proposed Significant New Use Rule (SNUR) for Asbestos |
| May 24, 2018 |
Comments on proposed user fees for administration of amended TSCA |
| May 23, 2018 |
Letter on finalizing the phase-out rule for methylene chloride paint removal products |
| April 16, 2018 |
Comments on draft guidance on expanded access to Confidential Business Information |
| January 25, 2018 |
Comments on the public meeting regarding approaches for identifying potential candidates for prioritization |
| January 19, 2018 |
Comments on progress implementing the new chemicals review program |
| January 12, 2018 |
Decabromodiphenyl ethers (decaBDE), Pentachlorothiophenol (PCTP), Hexachlorobutadiene (HCBD), Phenol, isopropylated, phosophate (3:1) (in these sections: main comments, technical report, EJSCREEN reports 1, 2, 3, and 4), and 2,4,6-Tris(tert-butyl) phenol (2,4,6-TTBP) |
| December 11, 2017 |
Letter discussing serious concerns with pre-manufacture notice (PMN)/new chemicals program |
| October 16, 2017 |
Letter relaying concerns about pre-manufacture notice (PMN)/new chemicals program |
| September 19, 2017 |
Comments on scoping documents |
| July 25, 2017 |
Letter critiquing scoping documents and problem formulation |
| May 24, 2017 |
Comments on standards for small manufacturers and processors |
| May 19, 2017 |
Comments on proposed rule restricting Trichloroethylene (TCE) in vapor degreasing |
| May 19, 2017 |
Comments on proposed rule restricting Methylene Chloride and N-methylpyrrolidone (NMP) in paint and coating removal |
| April 4, 2017 |
Letter opposing extension request for NMP/Methylene Chloride comment period |
| April 4, 2017 |
Letter opposing additional extension request for TCE vapor degreasing comment period |
| March 20, 2017 |
Comments on proposed prioritization procedures rule |
| March 20, 2017 |
Comments on proposed risk evaluation procedures rule |
| March 16, 2017 |
Comments on proposed rule restricting Trichloroethylene (TCE) in aerosol degreasing and spot cleaning |
| March 15, 2017 |
General comments on risk evaluation scoping process |
| March 15, 2017 |
Comments on scope of risk evaluation for: Asbestos, Carbon Tetrachloride (CTC), Hexabromocyclododecane (HBCD), Methylene Chloride, N-Methylpyrrolidone, and 1-Bromopropane (1-BP/nPB) |
| March 14, 2017 |
Comments on proposed inventory notification rule |
| February 6, 2017 |
Letter opposing extension request for both TCE rules’ comment periods |
| January 17, 2017 |
Comments on Pre-Manufacture Notice/New Chemicals Program |
| October 4, 2016 |
Letter regarding Confidential Business Information (CBI) substantiation requirements |
| August 9, 2016 |
Letter conveying recommendations for the first 10 chemicals to be evaluated under TSCA |
